Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?
about
sameAs
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinEfficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.Novel mechanisms in functional dyspepsia.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.Gastric perception thresholds are low and sensory neuropeptide levels high in helicobacter pylori-positive functional dyspepsia.Psychological stress and the severity of post-inflammatory visceral hyperalgesia.Functional dyspepsiaA 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factorsAssociation between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunctionPrevalence of Unexplained Upper Abdominal Symptoms in Patients with Migraine
P2860
Q28192701-0255FEF4-D3F2-4BC7-B1AE-1F82B201255DQ34252850-678DCDB5-F345-45C0-AD64-8E6AEEF60587Q34636856-D76263E5-053F-42F0-93E4-F41F63971124Q36474152-64873C34-F09D-4747-A6FE-F8E1F3E728D1Q36728938-F8846476-947F-4D16-BF6A-BF070DECE41FQ38445280-CA7B035E-6125-429C-B4F2-4AFA35DC3EABQ41979327-9E9C12C1-A040-4347-A4FD-3647C6BD9B17Q42704606-8BE2B866-3149-44B0-80F5-B0FB0298A878Q43216541-14FA0142-856D-4769-82D5-FA9E1F974E06Q44905463-CF306006-E645-4FC1-81C5-93FC5078A7F4Q46398819-9864A322-4153-4641-9B8F-44588B59654FQ51245157-6F59D102-BA03-44E2-9401-8559126607ECQ57789296-B18363A6-155F-4E89-9853-33BC2D115E74Q57789419-83730F91-6633-4CC7-8C08-AF2C6B781BA1Q57789445-1E55E369-20D9-4359-981F-87DCF950BC15Q57789585-A4E4A476-0902-45C8-979F-67C5712CD404
P2860
Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Do changes in visceral sensory ...... during treatment with aspirin?
@ast
Do changes in visceral sensory ...... during treatment with aspirin?
@en
Do changes in visceral sensory ...... during treatment with aspirin?
@nl
type
label
Do changes in visceral sensory ...... during treatment with aspirin?
@ast
Do changes in visceral sensory ...... during treatment with aspirin?
@en
Do changes in visceral sensory ...... during treatment with aspirin?
@nl
prefLabel
Do changes in visceral sensory ...... during treatment with aspirin?
@ast
Do changes in visceral sensory ...... during treatment with aspirin?
@en
Do changes in visceral sensory ...... during treatment with aspirin?
@nl
P2093
P356
P1433
P1476
Do changes in visceral sensory ...... during treatment with aspirin?
@en
P2093
Juergen Gschossmann
Lydia Buenger
Nicholas J Talley
P304
P356
10.1053/GAST.2002.36556
P407
P577
2002-11-01T00:00:00Z